The FASEB Journal, Vol 4, 3275-3283, Copyright © 1990 by The Federation of American Societies for Experimental Biology

REVIEWS

The two binding-site models of human IgG binding Fc gamma receptors

J Gergely and G Sarmay
Department of Immunology, Eotvos Lorand University, God, Hungary.

Fc receptors (FcR) are immunoglobulin-binding molecules that enable antibodies to perform several biological functions by forming a link between specific antigen recognition and effector cells. FcRs are involved in regulating antibody production as well. Most FcRs belong to the immunoglobulin superfamily, and show structural homology with each other and with their ligands. Recent data on the structure of IgG binding FcRs obtained from monoclonal antibodies and gene cloning studies, as well as on ligand binding capacity and fine specificity of the receptor binding site (or sites), are reviewed. The binding capacity and fine specificity of receptor binding sites, as well as the structure and conformation of the immunoglobulin ligands, play important roles in triggering FcR-mediated signals. In induction of signals, the interaction of the FcR with the CH2 domain of the IgGFc is decisive. The high-affinity Fc gamma RI possess one active binding site specific for contact residues that is located at the N-proximal end of the CH2 domain and is able to mediate both binding and signal transfer. The low-affinity Fc gamma RIII has two active binding sites: the CH3 domain-specific site, which mediates only binding; and the CH2 domain- specific site, which is responsible for binding and signaling. Similarly, the low-affinity Fc gamma RII on resting B cells has one site for CH2 and another for CH3 binding. The expression, release, and fine specificity of Fc gamma RII on B cells correlates with the cell cycle.

This article has been cited by other articles:

				P. L. Leopold, R. L. Wendland, T. Vincent, and R. G. Crystal Neutralized Adenovirus-Immune Complexes Can Mediate Effective Gene Transfer via an Fc Receptor-Dependent Infection Pathway. J. Virol., October 1, 2006; 80(20): 10237 - 10247. [Abstract] [Full Text] [PDF]

				A. J. da Silva, M. Brickelmaier, G. R. Majeau, Z. Li, L. Su, Y.-M. Hsu, and P. S. Hochman Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells J. Immunol., May 1, 2002; 168(9): 4462 - 4471. [Abstract] [Full Text] [PDF]

				Y. Huang, A. J. Fleming, S. Wu, G. Virella, and M. F. Lopes-Virella Fc-{{gamma}} Receptor Cross-Linking by Immune Complexes Induces Matrix Metalloproteinase-1 in U937 Cells via Mitogen-Activated Protein Kinase Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2533 - 2538. [Abstract] [Full Text] [PDF]

				A. Tamm, A. Kister, K. U. Nolte, J. E. Gessner, and R. E. Schmidt The IgG Binding Site of Human Fc[IMAGE]RIIIB Receptor Involves CC` and FG Loops of the Membrane-proximal Domain J. Biol. Chem., February 16, 1996; 271(7): 3659 - 3666. [Abstract] [Full Text] [PDF]